Enhancing the QUAlity and Transparency Of health Research

EQUATOR resources in German | Portuguese | Spanish

Blog Archives

26/07/2017 Guidance to develop individual dose recommendations for patients on chronic hemodialysis 14/05/2017 SPIRIT 2013 Statement: Defining standard protocol items for clinical trials 20/04/2016 Developing the Clarity and Openness in Reporting: E3-based (CORE) reference user manual for creation of clinical study reports in the era of clinical trial transparency 22/03/2016 Standardized outcomes reporting in metabolic and bariatric surgery 22/05/2015 Translating trial-based molecular monitoring into clinical practice: importance of international standards and practical considerations for community practitioners 13/02/2015 Using the spinal cord injury common data elements 04/02/2015 A new standardized format for reporting hearing outcome in clinical trials 29/01/2015 Reporting standards for angiographic evaluation and endovascular treatment of cerebral arteriovenous malformations 28/01/2015 How to report low-level laser therapy (LLLT)/photomedicine dose and beam parameters in clinical and laboratory studies 10/07/2013 Seven items were identified for inclusion when reporting a Bayesian analysis of a clinical study

Blog archives

Latest guest blogger

  • Why did we develop TIDieR-Placebo?

    The TIDieR reporting guideline helps authors fully report their interventions, so that they can be used by others. However, TIDieR only explicitly covers active interventions, not placebo controls. The developers of the new TIDieR-Placebo extension explain why it is needed Read More